Next generation gene control solutions for enhanced RNAi product development
Laverock's gene silencing platform provides programmable, stable, tunable and specific gene silencing activity, unlocking targets that may be non-tractable with current approaches. Our technology is inherently stable, avoiding bolus affects and epigenetic silencing, and has unparallel tunability – dialing gene expression to the precise level required for disease control. Our approach also minimises off-target effects by recoding miRNAs specifically expressed in the target cell type.
Our RNA design and screening capabilities can also support the development of conventional RNAi approaches – helping you design and identify the optimal silencing RNA using our high-throughput platform.
